focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Regulatory News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Amendment

28 Dec 2018 11:03

RNS Number : 7144L
Citigroup Global Markets Limited
28 December 2018
 

 

 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH

RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Citigroup Global Markets Limited

(b) Name of offeror/offeree in relation to whoserelevant securities this form relates:Use a separate form for each offeror/offeree

Shire plc

(c) Name of the party to the offer with which exemptprincipal trader is connected:

Shire plc

(d) Date dealing undertaken:

21 December 2018

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?If it is a cash offer or possible cash offer, state "N/A"

YESTakeda Pharmaceutical Company Limited

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

ADR

Purchase

11,903

USD 171.5000

USD 169.7100

ADR

Sale

11,203

USD 171.5000

USD 169.7100

5p ordinary

Purchase

1,385,721

USD 57.8352

USD 56.8522

5p ordinary

Purchase

1,576,795

GBP 45.8500

GBP 44.6250

5p ordinary

Sale

2,597,025

GBP 45.3050

GBP 44.6250

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description e.g. CFD

Nature of dealinge.g. opening/closing along/short position,increasing/reducing along/short position

Number of reference securities

Price per unit

5p ordinary

TRS

Closing Short Position

350

GBP 45.0426

5p ordinary

TRS

Closing Short Position

27,322

GBP 45.0426

5p ordinary

TRS

Closing Short Position

1,926

GBP 45.0426

5p ordinary

TRS

Opening Long Position

250,000

GBP 45.1800

5p ordinary

TRS

Closing Long Position

76

GBP 44.8950

5p ordinary

TRS

Closing Short Position

155

GBP 45.0750

5p ordinary

TRS

Closing Short Position

200

GBP 45.0700

5p ordinary

TRS

Closing Short Position

14,017

GBP 45.0713

5p ordinary

TRS

Closing Short Position

53

GBP 45.0900

5p ordinary

TRS

Closing Short Position

200

GBP 45.0700

5p ordinary

TRS

Closing Short Position

200

GBP 45.0650

5p ordinary

TRS

Closing Short Position

200

GBP 45.0700

5p ordinary

TRS

Closing Short Position

155

GBP 45.0650

5p ordinary

TRS

Closing Short Position

6,280

GBP 45.0717

5p ordinary

TRS

Closing Short Position

4,678

GBP 45.0682

5p ordinary

TRS

Closing Short Position

29

GBP 45.0650

5p ordinary

TRS

Closing Short Position

521,944

GBP 44.8992

5p ordinary

TRS

Closing Short Position

48

GBP 45.0750

5p ordinary

TRS

Closing Short Position

13

GBP 45.0600

5p ordinary

TRS

Closing Short Position

10

GBP 45.0750

5p ordinary

TRS

Increasing Short Position

818

GBP 44.8950

5p ordinary

TRS

Increasing Long Position

173

GBP 45.3050

5p ordinary

TRS

Increasing Long Position

179

GBP 45.2600

5p ordinary

TRS

Increasing Long Position

179

GBP 45.2750

5p ordinary

TRS

Increasing Long Position

178

GBP 45.2600

5p ordinary

TRS

Increasing Long Position

30

GBP 45.2850

5p ordinary

TRS

Increasing Long Position

176

GBP 45.2850

5p ordinary

TRS

Increasing Long Position

179

GBP 45.2750

5p ordinary

TRS

Increasing Long Position

1

GBP 45.3050

5p ordinary

TRS

Increasing Long Position

35

GBP 45.3000

5p ordinary

TRS

Increasing Long Position

178

GBP 45.2900

5p ordinary

TRS

Increasing Long Position

178

GBP 45.2700

5p ordinary

TRS

Increasing Long Position

179

GBP 45.2900

5p ordinary

TRS

Increasing Long Position

422

GBP 45.3028

5p ordinary

TRS

Increasing Long Position

148

GBP 45.2800

5p ordinary

TRS

Increasing Long Position

90

GBP 45.2700

5p ordinary

TRS

Reducing Long Position

265

GBP 44.8950

5p ordinary

TRS

Increasing Long Position

177

GBP 45.2950

5p ordinary

TRS

Increasing Long Position

179

GBP 45.2600

5p ordinary

TRS

Increasing Long Position

179

GBP 45.2600

5p ordinary

TRS

Increasing Long Position

51

GBP 45.2750

5p ordinary

TRS

Increasing Long Position

887

GBP 45.2886

5p ordinary

TRS

Increasing Long Position

183

GBP 45.2550

5p ordinary

TRS

Increasing Long Position

440

GBP 45.2901

5p ordinary

TRS

Closing Short Position

5,063

GBP 44.8950

5p ordinary

TRS

Closing Short Position

499

GBP 44.8950

5p ordinary

TRS

Closing Short Position

8,212

GBP 44.8950

5p ordinary

TRS

Closing Short Position

473,731

GBP 44.8950

5p ordinary

TRS

Increasing Long Position

105

GBP 44.8950

5p ordinary

TRS

Closing Short Position

40

GBP 45.2500

5p ordinary

TRS

Increasing Short Position

200,000

USD 57.8352

5p ordinary

TRS

Increasing Short Position

140,000

USD 57.0235

5p ordinary

TRS

Increasing Short Position

182,905

USD 56.8522

5p ordinary

TRS

Increasing Short Position

595,950

USD 56.9544

5p ordinary

TRS

Increasing Short Position

47,676

USD 56.8522

5p ordinary

TRS

Closing Short Position

15,328

GBP 44.8950

5p ordinary

TRS

Closing Short Position

52,297

GBP 44.8950

5p ordinary

TRS

Closing Short Position

930

GBP 44.8950

5p ordinary

TRS

Closing Short Position

9,665

GBP 44.8950

5p ordinary

TRS

Increasing Short Position

100,000

USD 56.8808

5p ordinary

TRS

Increasing Short Position

119,190

USD 57.3242

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing,selling,varying etc.

Number of securities towhich option relates

Exercise price per unit

Typee.g. American,European etc.

Expiry date

Option money paid/ received per unit

 

 

(ii) Exercise

 

 

Class of relevant security

Product description e.g. call option

Exercising/ exercised against

Number ofsecurities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

 

Class of relevant security

Nature of dealinge.g. subscription, conversion

Details

Price per unit(if applicable)

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding,formal or informal, relating to relevant securities which may be an inducement to dealor refrain from dealing entered into by the exempt principal trader making thedisclosure and any party to the offer or any person acting in concert witha party to the offer:

 

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, betweenthe exempt principal trader making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

 

If there are no such agreements, arrangements or understandings, state "none"

None

 

Date of disclosure:

28 December 2018

Contact name:

Damian Flanagan

Telephone number:

028 90409676

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory InformationService and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEREAFAPAEAPFFF
Date   Source Headline
8th Jan 20195:30 pmGNWDirector/PDMR Shareholding
8th Jan 20193:20 pmRNSForm 8.3 - Shire plc
8th Jan 20193:19 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20193:13 pmRNSForm 8.3 - Shire plc
8th Jan 20193:07 pmRNSForm 8.5 (EPT/NON-RI)
8th Jan 20192:28 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20192:23 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20192:21 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20191:57 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20191:27 pmRNSForm 8.3 - Shire plc
8th Jan 201912:31 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 201912:29 pmRNSForm 8.3 - Takeda Pharmaceutical
8th Jan 201912:27 pmRNSForm 8.3 - Shire plc
8th Jan 201911:42 amRNSForm 8.5 (EPT/NON-RI)
8th Jan 201911:33 amRNSForm 8.5 (EPT/NON-RI)- Shire Plc
8th Jan 201910:49 amRNSForm 8.5 (EPT/RI)
8th Jan 201910:41 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 201910:26 amRNSForm 8.5 (EPT/RI)- Shire plc
8th Jan 20199:51 amRNSForm 8.3 - Shire Plc
8th Jan 20198:44 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
8th Jan 20197:00 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20197:00 amGNWScheme becomes effective
7th Jan 20195:00 pmGNWHolding(s) in Company
7th Jan 20193:42 pmRNSForm 8.5 (EPT/RI) - Amendment
7th Jan 20193:20 pmRNSForm 8.3 - Shire plc
7th Jan 20193:02 pmRNSForm 8.3 - Shire plc
7th Jan 20193:00 pmRNSForm 8.5 (EPT/NON-RI)
7th Jan 20193:00 pmRNSForm 8.3 - Shire plc
7th Jan 20192:59 pmRNSForm 8.3 - Takeda Pharmaceutical
7th Jan 20192:50 pmPRNForm 8.3 - Shire Plc
7th Jan 20192:49 pmRNSForm 8.3 - Shire plc
7th Jan 20192:47 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 20192:45 pmBUSForm 8.3 - Shire plc
7th Jan 20191:55 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 20191:54 pmRNSForm 8.3 - Shire plc
7th Jan 20191:39 pmRNSForm 8.3 - [Shire Plc]
7th Jan 20191:32 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
7th Jan 20191:29 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
7th Jan 201912:57 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201912:56 pmRNSForm 8.3 - Shire plc
7th Jan 201912:42 pmRNSForm 8.5 (EPT/NON-RI)
7th Jan 201911:52 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201911:43 amBUSForm 8.3 - SHIRE PLC
7th Jan 201911:30 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201911:27 amRNSForm 8.3 - Shire plc
7th Jan 201911:01 amRNSForm 8.5 (EPT/RI)- Shire plc
7th Jan 201910:59 amRNSForm 8.5 (EPT/NON-RI)- Shire Plc
7th Jan 201910:35 amRNSForm 8.5 - Shire plc
7th Jan 201910:16 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
7th Jan 201910:13 amRNSForm 8.5 (EPT/RI) - Amendment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.